QGEN is expected to report earnings to rise 11.56% to 60 cents per share on July 23
Q2'26
Est.
$0.60
Q1'26
Est.
$0.54
Q4'25
Est.
$0.62
Q3'25
Beat
by $0.02
Q2'25
Est.
$0.60
The last earnings report on May 06 showed earnings per share of 54 cents, meeting the estimate of 54 cents. With 3.53M shares outstanding, the current market capitalization sits at 7.67B.
A.I. Advisor
published General Information
General Information
a manufacturer of sample and assay technology products for preanalytical sample preparations
A.I.dvisor indicates that over the last year, QGEN has been loosely correlated with BRKR. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if QGEN jumps, then BRKR could also see price increases.
QGEN in +5.24% Uptrend, advancing for three consecutive days on June 04, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where QGEN advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 10-day moving average for QGEN crossed bullishly above the 50-day moving average on June 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 180 cases where QGEN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on QGEN as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
QGEN moved below its 50-day moving average on June 22, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QGEN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
QGEN broke above its upper Bollinger Band on May 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.246) is normal, around the industry mean (12.431). P/E Ratio (18.490) is within average values for comparable stocks, (145.825). Projected Growth (PEG Ratio) (0.913) is also within normal values, averaging (1.482). Dividend Yield (0.007) settles around the average of (0.008) among similar stocks. P/S Ratio (3.546) is also within normal values, averaging (7.245).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. QGEN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QGEN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
